Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Connect Biopharmaceuticals
Biotech
Connect blames 'challenging environment' for lead program pause
Connect Biopharma cited the icy funding environment for halting a global phase 3 program for its dermatitis asset while it seeks out a partner.
James Waldron
Jan 3, 2023 7:55am
Chasing BMS and Pfizer, Connect fails ulcerative colitis trial
May 4, 2022 7:53am
Connect Biopharma touts positive data for Dupixent rival
Nov 22, 2021 5:30am
Connect Biopharma nabs $115M as it eyes rivalry with Dupixent
Aug 25, 2020 7:25am